Date | Title | Description |
19.11.2021 | Invitation... | STOCKHOLM — November 19, 2021 ... |
18.11.2021 | Nordic Nan... | Nordic Nanovector ASA (OSE: NA... |
16.11.2021 | Spruce Bio... | Planned Initiation of Phase 2 ... |
16.11.2021 | Spruce Bio... | SAN FRANCISCO–(BUSINESS WIRE)–... |
15.11.2021 | Carisma Th... | PHILADELPHIA, November 12, 202... |
15.11.2021 | Jakob Lind... | STOCKHOLM — November 15, 2021 ... |
11.11.2021 | Xeris Biop... | Acquisition of Strongbridge Bi... |
10.11.2021 | Targovax a... | Oslo, Norway, 9 November 2021 ... |
10.11.2021 | Aprea Ther... | BOSTON, Nov. 08, 2021 (GLOBE N... |
10.11.2021 | Nordic Nan... | Abstract by The Health Policy ... |
10.11.2021 | Fusion Pha... | FPI-1434 Phase 1 multi-dose da... |
10.11.2021 | Nordic Nan... | Oslo, Norway, 8 November 2021;... |
06.11.2021 | Aprea Ther... | BOSTON, Nov. 04, 2021 (GLOBE N... |
04.11.2021 | Oncopeptid... | STOCKHOLM — November 4, 2021 —... |
04.11.2021 | Interim re... | 2021-11-04;Gothenburg, Novembe... |
04.11.2021 | Targovax A... | Oslo, Norway, 4 November 2021 ... |
04.11.2021 | BONESUPPOR... | Lund, Sweden, 08:00 CEST, Nove... |
03.11.2021 | Fusion Pha... | – Eric Burak, Ph.D. Appointed ... |
03.11.2021 | Xeris Biop... | CHICAGO–(BUSINESS WIRE)–Nov. 2... |
03.11.2021 | Pulmonx Re... | REDWOOD CITY, Calif., Nov. 02,... |
03.11.2021 | Vicore’s C... | · The results showed nearly 50... |
28.10.2021 | BONESUPPOR... | Lund, Sverige, 10.00 CET, 28 O... |
27.10.2021 | Targovax A... | Oslo, Norway, 27 October 2021 ... |
27.10.2021 | HelloBette... | Digital health pioneer closes ... |
27.10.2021 | Pulmonx to... | REDWOOD CITY, Calif., Oct. 26,... |
25.10.2021 | Lancet’s E... | · The trial showed that C21 re... |
22.10.2021 | Targovax i... | Oslo, Norway, 22 October 2021 ... |
22.10.2021 | Oncopeptid... | STOCKHOLM — October 22, 2021 —... |
21.10.2021 | Germany is... | Berlin/Hamburg, 19 October 202... |
21.10.2021 | Fusion Pha... | Single and multiple doses of F... |
21.10.2021 | Targovax A... | Oslo, Norway, 20 October 2021 ... |
21.10.2021 | Nordic Nan... | Oslo, Norway, 19 October 2021;... |
14.10.2021 | Lakeside i... | Doctrin is a Swedish healthtec... |
13.10.2021 | Aro Biothe... | Philadelphia, PA, October 7, 2... |
07.10.2021 | Precirix d... | Brussels, Belgium, 6 October 2... |
07.10.2021 | Strongbrid... | DUBLIN, Ireland and TREVOSE, P... |
30.09.2021 | Targovax A... | Oslo, Norway, 30 September 202... |
29.09.2021 | Fusion Pha... | HAMILTON, ON and BOSTON, Sept.... |
28.09.2021 | BONESUPPOR... | Lund, Sweden, 08:00 CET, 28-09... |
25.09.2021 | Strongbrid... | DUBLIN, Ireland and TREVOSE, P... |
25.09.2021 | Targovax g... | Patent protection of ONCOS-102... |
22.09.2021 | Pulmonx An... | Blue Cross Blue Shield of Mich... |
22.09.2021 | Vicore obt... | Gothenburg, September 22, 2021... |
22.09.2021 | CARISMA Th... | PHILADELPHIA, Sept. 22, 2021 /... |
22.09.2021 | Vicore to ... | Webinar on Thursday, September... |
21.09.2021 | Aprea Ther... | BOSTON, Sept. 20, 2021 (GLOBE ... |
21.09.2021 | Hemab Appo... | Copenhagen, Denmark and Boston... |
21.09.2021 | Fusion Pha... | HAMILTON, ON and BOSTON, Sept.... |
17.09.2021 | Vicore sta... | Gothenburg, September 17, 2021... |
17.09.2021 | Targovax A... | Oslo, Norway, 16 September 202... |
15.09.2021 | Webcast fo... | Oncopeptides will present data... |
15.09.2021 | Strongbrid... | DUBLIN, Ireland and TREVOSE, P... |
15.09.2021 | Precirix a... | Brussels, Belgium and Kjeller,... |
15.09.2021 | Aprea Ther... | BOSTON, Sept. 14, 2021 (GLOBE ... |
15.09.2021 | Oncopeptid... | STOCKHOLM — September 11, 2021... |
15.09.2021 | Nordic Nan... | Nordic Nanovector ASA (OSE: NA... |
15.09.2021 | Study resu... | Lund, Sweden, 19:40 CET, 09 09... |
03.09.2021 | Regulatory... | STOCKHOLM — September 2, 2021 ... |
28.08.2021 | Oncopeptid... | STOCKHOLM — August 27, 2021 — ... |
28.08.2021 | Vicore str... | Gothenburg, August 27, 2021 – ... |
28.08.2021 | Targovax A... | Oslo, Norway, 27 August 2021 –... |
28.08.2021 | Nordic Nan... | Nordic Nanovector ASA (OSE: NA... |
27.08.2021 | Interim re... | Gothenburg, August 26, 2021 – ... |
26.08.2021 | Spruce Bio... | Phase 2 Program in Pediatric C... |
21.08.2021 | Oncopeptid... | Launch dynamics encouraging, b... |
19.08.2021 | Targovax A... | August 18, 2021 Press release ... |
18.08.2021 | Precirix e... | Brussels, Belgium and Noáin, S... |
14.08.2021 | VTX-801 Re... | Paris, France and New York, NY... |
14.08.2021 | Fusion Pha... | Fusion and TRIUMF to collabora... |
14.08.2021 | Aprea Ther... | BOSTON, Aug. 12, 2021 (GLOBE N... |
13.08.2021 | Aprea Ther... | BOSTON, Aug. 12, 2021 (GLOBE N... |
13.08.2021 | Invitation... | STOCKHOLM — August 12, 2021 — ... |
12.08.2021 | Spruce Bio... | Clearance of IND for Treatment... |
11.08.2021 | Fusion Pha... | Phase 1 study of FPI-1434 prog... |
07.08.2021 | Aprea Ther... | BOSTON, Aug. 05, 2021 (GLOBE N... |
06.08.2021 | Strongbrid... | ~ Reports KEVEYIS® (dichlorphe... |
05.08.2021 | Pulmonx Re... | REDWOOD CITY, Calif., Aug. 03,... |
05.08.2021 | Aro Biothe... | Philadelphia, PA, August 4, 20... |
05.08.2021 | Nordic Nan... | Oslo, Norway, 3 August 2021;No... |
04.08.2021 | SynOx Ther... | Dublin, Ireland, August 3, 202... |
30.07.2021 | Fusion Pha... | HAMILTON, ON and BOSTON, July ... |
29.07.2021 | Regulatory... | July 28, 2021Regulatory;STOCKH... |
28.07.2021 | SynOx Ther... | Dublin, Ireland, July 27, 2021... |
28.07.2021 | Pulmonx An... | Newly Published Data Shows Pos... |
23.07.2021 | Successful... | Copenhagen, Denmark and Boston... |
22.07.2021 | Pulmonx to... | REDWOOD CITY, Calif., July 20,... |
22.07.2021 | Aprea Ther... | BOSTON, July 21, 2021 (GLOBE N... |
17.07.2021 | BONESUPPOR... | Lund, Sweden, 08:00 CEST, July... |
15.07.2021 | Strongbrid... | ~ Study Confirms Long-Term Tre... |
09.07.2021 | BONESUPPOR... | Lund, Sverige, 10.00 CET, 8 Ju... |
09.07.2021 | Updated re... | STOCKHOLM — July 8, 2021 — Onc... |
08.07.2021 | Adcendo Ap... | • Experienced Industry Leader ... |
02.07.2021 | Targovax A... | Oslo, Norway, 1 July 2021 – Ta... |
02.07.2021 | Nordic Nan... | Oslo, Norway, 1 July 2021;Nord... |
25.06.2021 | Spruce Bio... | Dr. Ways’ Expertise in Late-St... |
25.06.2021 | InCarda Th... | San Francisco, CA – June 23, 2... |
23.06.2021 | Nordic Nan... | Oslo, Norway, 22 June 2021;Nor... |
23.06.2021 | Targovax r... | Oslo, Norway 22 June 2021 – Ta... |
22.06.2021 | Doctrin ra... | 21 JUNE 2021;Swedish health te... |
22.06.2021 | Spruce Bio... | Tildacerfont was Evaluated in ... |
18.06.2021 | BONESUPPOR... | Lund, Sweden, 10:00 CET, 17 06... |